红细胞
红细胞输注
经济短缺
医学
血液管理
重症监护医学
输血
血红蛋白
红细胞
诱导多能干细胞
免疫学
化学
内科学
语言学
胚胎干细胞
政府(语言学)
哲学
基因
生物化学
标识
DOI:10.1016/j.cll.2021.07.004
摘要
Red blood cell (RBC) transfusions are necessary to increase a patient’s oxygen carrying capacity. The optimal transfusion trigger remains elusive, but a restrictive transfusion trigger of 7 g/dL has been shown in studies to reduce RBC transfusions without adversely affecting patient outcomes. Patient blood management programs have been shown effective at reducing RBC transfusions. Hemoglobin-based oxygen carriers and induced pluripotent stem cell derived RBCs are being developed to help mitigate RBC shortages and RBC transfusion limitations. Numerous challenges still exist that need to be overcome before they can have widespread clinical use.
科研通智能强力驱动
Strongly Powered by AbleSci AI